Lexagene Holdings Inc
XTSX:LXG
Lexagene Holdings Inc
XTSX:LXG
Price:
0.105
CAD
Market Cap:
CA$14.8m
Relative Value
There is not enough data to reliably calculate the relative value of LXG.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LXG
Relative Value
Base Case
Not Available
Multiples Across Competitors
LXG Competitors Multiples
Lexagene Holdings Inc Competitors
Lexagene Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Lexagene Holdings Inc
XTSX:LXG
|
14.8m CAD | 55.5 | -0.7 | -0.7 | -0.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
191.3B USD | 4.3 | 29 | 16.5 | 22.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.7B USD | 17 | 59.9 | 45.6 | 55.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
139.6B USD | 5.5 | 42.8 | 21.7 | 26.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
133.7B USD | 3.8 | 27.9 | 15.6 | 22.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
115.8B USD | 6 | 41.5 | 24.6 | 33.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59B USD | 2.7 | 35.1 | 12.8 | 21.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR | 2 | 22 | 12.5 | 17.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.8B USD | 12 | 48.8 | 34.9 | 38.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.7B USD | 7.7 | 33 | 23.4 | 25.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39B USD | 7.2 | 26.2 | 18.5 | 20.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
